Candice Horbacz
The year 2026 marks a critical juncture for state governments across the United States as they confront the complex challenge of taxing a burgeoning array of nicotine products. The nicotine industry has undergone a profound transformation, moving beyond the traditional dominance of combustible cigarettes to offer consumers a diverse range of alternatives, many of which present a significantly reduced harm profile. As these innovative products gain regulatory approval and market traction, states are grappling with how to integrate them into existing tax structures designed for a bygone era of tobacco consumption.
The Evolving Nicotine Landscape: A Paradigm Shift
For decades, the nicotine market was synonymous with cigarettes, a product whose devastating health consequences are well-documented. However, advancements in product technology and a growing public health emphasis on harm reduction have ushered in a new generation of nicotine delivery systems. Products such as oral pouches, sophisticated vaping devices (e-cigarettes), and heated tobacco products (HTPs) are now legally authorized for sale in the U.S. by the Food and Drug Administration (FDA). This authorization, granted through a rigorous Premarket Tobacco Product Application (PMTA) process, signifies that these products have met specific public health standards, including demonstrating that their marketing would be "appropriate for the protection of the public health."
While the number of FDA-authorized products available in the U.S. is still a fraction of those found globally or awaiting review, their presence on American shelves necessitates a fundamental rethinking of tobacco taxation. Unlike traditional cigarettes, which are nearly uniform in size, weight, and packaging (typically 20-cigarette packs), these alternative products are incredibly varied. Oral pouches come in different nicotine strengths and flavors; vapes differ in e-liquid volume, nicotine concentration, and device type (open vs. closed systems); and HTPs, while containing tobacco, deliver nicotine by heating rather than burning, fundamentally altering their risk profile compared to conventional cigarettes. This inherent diversity challenges the simplicity of established tax mechanisms and demands innovative legislative responses.
The Regulatory Backdrop: FDA’s Role in Product Authorization
The FDA’s authorization process for novel tobacco products is a cornerstone of the current landscape. Under the Family Smoking Prevention and Tobacco Control Act of 2009, manufacturers must submit PMTAs for new tobacco products. These applications require extensive scientific data demonstrating that permitting the product to be marketed would be appropriate for the protection of public health. This often involves evaluating potential risks and benefits to the population as a whole, including users and non-users, and considering the likelihood of product initiation by youth and cessation by current tobacco users.
As of early 2026, the FDA has authorized a select number of e-cigarette and heated tobacco products, deeming them appropriate for public health protection. Some products have even received Modified Risk Tobacco Product (MRTP) designations, allowing manufacturers to communicate to consumers that these products expose them to fewer or reduced levels of harmful substances compared to cigarettes. This regulatory validation is crucial because it differentiates these products from illicit or unauthorized alternatives and underscores their potential role in public health strategies focused on harm reduction. However, the regulatory rigor does not automatically translate into clear tax policy, leaving states to navigate the fiscal implications of these scientifically validated, yet often misunderstood, products.
Traditional Taxation: A Mismatch for Modern Products
Historically, tobacco taxation has evolved along two primary lines in the United States. Every state currently levies a tax on combustible cigarettes, a system that is relatively straightforward due to the product’s standardization. Cigarette taxes are typically defined as a tax per cigarette, making it simple to calculate based on the standard 20-cigarette pack. Tax-paid stamps are then affixed to packs, ensuring compliance and ease of collection.
Beyond cigarettes, every state also taxes what are commonly referred to as "other tobacco products" (OTPs). This broad category encompasses products like loose tobacco, snuff, and chewing tobacco. However, the exact items included under the OTP umbrella can vary significantly from state to state. Given the diverse nature of products within this category, states have historically employed two main taxation methods: an ad quantum weight-based tax, where the tax is levied per ounce or gram, or an ad valorem tax, which is calculated as a percentage of the wholesale price.
The emergence of alternative tobacco products (ATPs) – particularly e-cigarettes and modern oral pouches – has exposed the limitations of these traditional tax definitions. Many of these newer products, such as nicotine pouches, do not contain tobacco leaf at all, making it difficult to classify them under existing OTP statutes without redefinition. Vaping e-liquids, while containing nicotine derived from tobacco, are also distinct from traditional tobacco products. Even heated tobacco products, which do contain tobacco, present a challenge: policymakers may hesitate to apply the same heavy tax burden as conventional OTPs, given their reduced-harm potential. This necessitates either a significant redefinition of the OTP category or, more commonly, the creation of entirely new tax categories specifically for ATPs.
The Patchwork of State Taxation: Inconsistency Reigns
The lack of a unified federal approach to ATP taxation has led to a highly inconsistent and fragmented state-by-state landscape. Most states have acknowledged the need for specific taxation of vaping products and e-cigarettes, but there is little consensus on how these taxes should be structured or what rates should apply. As of January 2025, 33 states and the District of Columbia levied an excise tax on vaping products. However, the methodologies vary wildly:
- Ad Valorem Taxes: Some states impose a tax based on a percentage of the manufacturer’s, wholesale, or retail price. This approach offers flexibility but can lead to lower revenues if product prices decrease.
- Ad Quantum Taxes: Other states tax based on product volume (e.g., cents per milliliter of e-liquid) or the number of cartridges. This method can be more stable in terms of revenue but might not account for varying nicotine strengths or product costs.
- Bifurcated Systems: A few states have adopted complex systems that differentiate between "open" vaping systems (where users can refill tanks with e-liquid) and "closed" systems (pre-filled pods or cartridges), applying different tax structures and rates to each.
The taxation of modern oral pouches is even less developed. As 2026 begins, only 18 states have implemented taxes on these products, reflecting the relatively newer market penetration and the ongoing debate about their classification and appropriate tax levels. This inconsistency creates significant challenges for manufacturers operating across state lines, complicates consumer understanding, and can inadvertently foster cross-border purchasing to avoid higher taxes.
Legislative Momentum: Key State Proposals for 2026
The legislative sessions of 2026 are expected to be active, with numerous states eyeing new or increased ATP taxes. While proposals are subject to change during the legislative process, several key initiatives highlight the prevailing trends and debates:
Delaware: Broadening the Tax Base
Delaware Governor Matt Meyer’s proposed 2027 budget includes significant changes to tobacco and nicotine product taxation. Beyond an increase in the existing tax on OTPs, the proposal specifically targets vapor products, advocating for a tax increase to 10 cents per milliliter. This move reflects a growing trend towards volume-based taxation for e-liquids, which some policymakers view as a more direct way to tax consumption regardless of product price.
Nebraska: Seeking Parity, Raising Rates
Nebraska’s LB 1238 aims to standardize excise tax rates across a broad spectrum of products, including all tobacco, electronic nicotine delivery systems, nicotine analogues, and other ATPs. The bill proposes setting the tax rate for these products at 30 percent of the wholesale cost. If passed, this would represent a substantial tax increase for many ATPs, particularly those previously untaxed or taxed at lower rates, under the principle of taxing all nicotine products similarly.
New York: Layered Taxation and Expanded Definitions
Governor Hochul’s 2027 Executive Budget for New York includes multiple excise tax increases for ATPs, reflecting the state’s aggressive stance on public health and revenue generation. The proposal seeks to expand the state’s definition of OTP to explicitly include modern oral pouches, subjecting them to New York’s considerable 75 percent wholesale OTP tax rate. Furthermore, the state intends to add a $0.55 per unit tax on vapor products, atop the existing 20 percent retail tax. This represents a complex bifurcated system, combining both an ad valorem (percentage of retail price) and an ad quantum (per unit) tax, potentially making New York’s vaping tax one of the most intricate and highest in the nation.
Vermont: Pioneering Nicotine-Differentiated Taxes
Vermont’s S-0198 introduces a groundbreaking, yet controversial, approach by expanding the definition of OTP or "tobacco substitute" to encompass nicotine pouches and electronic vaping devices. Crucially, S-0198 would establish what is believed to be the country’s first tax differentiated by nicotine content. Under the proposal, tobacco substitutes with less than 5 mg/g nicotine would be taxed at 92 percent of the wholesale price, aligning with the current OTP rate. However, products with 5 mg/g or more nicotine would face an even higher rate of 100 percent of the wholesale price. Most vaping products would likely fall into this higher tax category. While intended to address perceived harm based on nicotine concentration, critics argue there is limited economic or health justification for such a direct nicotine-based tax, especially without clear evidence that higher nicotine concentrations directly correlate with disproportionately higher public health costs when consumed via reduced-harm products.
Washington: Shifting Tax Structures and MRTP Incentives
Washington State’s HB 2382 proposes a significant overhaul of its vaping tax system. It would replace the state’s existing per milliliter vaping tax with a substantial 95 percent wholesale tax, marking a considerable tax increase. Moreover, the bill targets products that have qualified as Modified Risk Tobacco Products (MRTPs) by cutting their tax discount in half (effectively increasing their tax). This move is particularly concerning for public health advocates who argue that reducing tax incentives for products deemed less harmful by the FDA undermines efforts to encourage smokers to switch to safer alternatives.
Utah: Reclassifications and Repealed Reductions
Utah’s HB 0337 aims to simplify its tax code by repealing existing separate tax categories for smokeless tobacco and nicotine pouches, instead moving these products into the broader OTP category. This reclassification means these products would be subjected to Utah’s OTP tax rate of 86 percent of the wholesale price. Like Washington’s proposal, HB 0337 also seeks to repeal the 50 percent reduction currently given to MRTPs, resulting in a tax increase for these products and potentially disincentivizing their use as a harm reduction tool.
The Policy Conundrum: Balancing Public Health and Fiscal Needs
The legislative activity in 2026 underscores the profound policy conundrum facing states. On one hand, there is a legitimate public health interest in taxing nicotine products to discourage initiation, particularly among youth, and to generate revenue for health programs. On the other hand, a growing body of scientific evidence and regulatory action (from the FDA) suggests that not all nicotine products are equally harmful. The core challenge is how to design tax policies that appropriately reflect these varying risk profiles while still meeting fiscal objectives and preventing unintended consequences, such as driving consumers back to more harmful combustible cigarettes or into illicit markets.
Public health advocates often emphasize the need to prevent youth access and to tax nicotine products sufficiently to deter use. However, some also recognize the potential of reduced-harm products for adult smokers unable or unwilling to quit nicotine entirely. Industry stakeholders, particularly manufacturers of ATPs, frequently argue for differentiated taxation, asserting that taxing all nicotine products equally or taxing reduced-harm products too heavily contradicts public health harm reduction principles. They often point to the risk of creating a regulatory environment that inadvertently protects the market share of the most harmful product: combustible cigarettes.
Expert Frameworks: Guiding Principles for Harm Reduction Taxation
Recognizing the complexity, organizations like the Tax Foundation have developed frameworks for taxing alternative tobacco products that prioritize harm reduction. These frameworks typically assign product categories based on several key criteria:
- Degree of Harm: The primary factor, with less harmful products receiving lower tax rates.
- Substitutability for Combustible Cigarettes: How easily the product can replace traditional cigarettes for current smokers.
- Ease of (Mass) Consumption: Products that can be consumed quickly or discreetly might warrant different consideration.
- Addictiveness: While all nicotine products carry addiction potential, differences in delivery mechanisms might be considered.
Under such a framework, less harmful products would ideally receive a tax rate significantly lower – typically 50-100 percent less – than the tax rate applied to combustible cigarettes. The rationale is that such price differentials actively incentivize consumers to switch from high-harm products to lower-harm alternatives. By linking ATP tax rates as a percentage of cigarette tax rates, policymakers can create a dynamic system that adapts to changes in cigarette taxes while maintaining a consistent harm-based differential. This approach offers a pragmatic path for legislators to adopt at any level of government, aiming to align fiscal policy with public health goals.
Broader Implications: Market Dynamics, Public Health Outcomes, and Revenue Stability
The decisions made by state legislatures in 2026 will have far-reaching implications. For market dynamics, inconsistent or excessively high taxes on ATPs could stifle innovation, disadvantage legitimate manufacturers, and potentially fuel black markets where unregulated and untaxed products proliferate, posing additional public health risks. Conversely, well-designed tax policies could foster a robust legal market for reduced-harm products, providing adult smokers with accessible alternatives.
In terms of public health outcomes, the stakes are high. Tax policies that effectively differentiate between products based on harm could accelerate the decline in combustible cigarette use, leading to significant improvements in public health. However, policies that tax all nicotine products uniformly or heavily tax less harmful alternatives risk disincentivizing switching and could inadvertently prolong the public health burden associated with traditional cigarettes. The Vermont proposal, with its nicotine-differentiated tax, illustrates an attempt to align tax with perceived harm, but its effectiveness and justification remain subjects of intense debate. Similarly, proposals to reduce MRTP tax incentives, such as those in Washington and Utah, run counter to the principle of encouraging less harmful choices.
For revenue stability, states face a delicate balancing act. While new taxes on ATPs can generate revenue, over-taxation could reduce sales, diminish the tax base, and create an unpredictable revenue stream. Furthermore, as the market continues to evolve and more products receive FDA authorization, the need for agile and adaptable tax policies will only intensify.
Conclusion: Charting a Course for Responsible Taxation
Creating effective public policy around new and innovative products is inherently challenging. As the FDA continues to grant marketing approval to a growing number of ATPs, more of these products will become available to U.S. consumers. Establishing appropriate and forward-looking tax policy is essential not only to ensure the creation of compliant, legal markets but also to play a crucial role in public health by encouraging adult smokers to transition towards less harmful alternatives. The legislative discussions and proposals unfolding in states like Delaware, Nebraska, New York, Vermont, Washington, and Utah in 2026 are not merely about collecting revenue; they are about shaping the future of nicotine consumption and public health in America. The ability of states to adopt nuanced, harm-reduction-focused tax policies will be a defining factor in this ongoing evolution.
